Syndax Pharmaceuticals : Modification to Rights of Security Holders - Form 8-K
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to... | June 11, 2023
Source: marketscreener.com
Stay updated with breaking news from Former Address. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to... | June 11, 2023
Wowi_8k.htm UNITED STATES SECURITIES AND EXCHANGE... | May 17, 2023
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to... | May 17, 2023
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to... | May 17, 2023
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT... | May 16, 2023